Fundraising Fox
Prolog Ventures
Venture capitalClayton · Series A–Late Stage · 6 people tracked
Also known as PROLOG VENTURES HL II, LLC
Find your way into Prolog Ventures
553 people in our graph share verified history with the Prolog Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Prolog Ventures backs early-stage companies advancing healthy lives in a healthy world. Its investment interests span consumer health and wellness, healthy foods and beverages, agriculture and sustainability, and health services. Portfolio examples include premium sparkling water, healthy children's foods, planet-friendly cover crops, and on-demand massage therapy, reflecting a focus on products and services that improve human and environmental health.
Source: firm website, verified Sep 29, 2026.
Team · 6 people
from curated & public directories
Founder mafia
2 people who came through Prolog Ventures went on to found or lead other companies.
What they invest in
from 19 of 32 portfolio companiesHealthtech ×9Biotech ×7Medical Devices ×6AgTech ×4AI & Machine Learning ×3Digital Health ×3Circular Economy ×2Cleantech ×2
HQs:United States×16Belgium×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2020 · 22019 · 12018 · 12017 · 32016 · 22015 · 12012 · 22011 · 113 dated
CareDox (operating as SchoolCare) provides a digital health record platform for K-12 school nurse offices that manages immunizations, chronic disease information, and student health compliance reporting.
Digital HealthEdTechHealthtechForest Hills, US
Hesky Kutscher(Executive Officer, Director)in
BoardGreg Goff(Director)Eyal Niv(Director)
Board seatIlya Nykin· per SEC Form D
Co-investorsKima Ventures7wire VenturesDigitalis VenturesFirst Round CapitalStartUp HealthTEXO Ventures+1 more
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods.
AgTechBiotechSt. Louis, US
Jeffrey Staub(Executive Officer, Director)inElizabeth Gallegos(Executive Officer)in
BoardMartha Schlicher(Executive Officer, Director)inCharles Bolten(Director)Dave Duncan(Director)
Board seatBrian Clevinger· per SEC Form D · $3.5M raise · filed Mar 2021
Co-investorsBioGenerator VenturesFulcrum Global CapitaliSelect FundMissouri Technology CorporationCultivation Capital
Foster City, US
Gregory Jensen(Executive Officer)inWolfgang Daum(Executive Officer, Director)in
BoardPaul Conley(Director)Mike Lucero(Director)John Steuart(Executive Officer)
Board seatBrian Clevinger· per SEC Form D · $16.1M raise · filed Sep 2016
On-demand massage service connecting customers with licensed massage therapists.
New York, US
BoardSamer Hamadeh(Executive Officer, Director)inRyan Freedman(Director)
Board seatIlya Nykin· per SEC Form D
Co-investorsAlpaca VCCorigin VenturesECP GrowthFJ LabsGrit Capital PartnersHemisphere Ventures LLC+7 more
Benson Hill develops soybean seed varieties using plant genetics and AI-driven plant science to produce more nutritious and energy-dense soy for agriculture and food markets.
AgTechAI & Machine LearningFoodTech
Co-investorsActivant CapitalBioGenerator VenturesGV (Google Ventures)iSelect FundLewis & Clark VenturesManta Ray Ventures+2 more
CleanSlate UV manufactures UV-C sanitization devices for mobile phones and portable electronics, serving healthcare facilities, hotels, and other institutions seeking to reduce pathogenic contamination on high-touch devices.
CleantechHardwareHealthtechMedical Devices
Co-investorsMaple Leaf AngelsNEXT Canada
CoverCress Inc. develops agricultural products and seeds that enable farmers to convert idle winter fields into profitable crops.
AgTechCleantechClimate TechEnergyOlivette, US
Jim Hedges(CEO)in
Co-investorsBioGenerator VenturesFulcrum Global CapitalPrelude VenturesCultivation Capital
Spindrift produces sparkling water beverages with real fruit juice and zero added sugar for consumers seeking refreshing drinks with natural ingredients.
ConsumerDirect to ConsumerFoodTech
Bill(Founder & Chairman)
Co-investorsAlmanac Insights
Neurolutions develops IpsiHand, a brain-computer interface therapy system for stroke survivors to improve arm and hand movement at home.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAscension VenturesExcelestar VenturesK2 HealthVentures
Kinnos makes Highlight, a colorant additive for disinfectant wipes that provides real-time visual feedback on surface coverage and cleaning technique to healthcare facilities.
HealthtechMedical DevicesBrooklyn, US
Jason Kang(Executive Officer)inKevin Tyan(Executive Officer)inKatherine Jin(Executive Officer)in
Co-investorsPartnership Fund for NYC
Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms.
BiotechDigital HealthHealthtechMedical Devices
Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease.
AI & Machine LearningBiotechDigital HealthMedical Devices
Co-investorsPlains Ventures
Revive is a real estate development company focused on sustainable urban housing projects and mixed-use property development in Belgium and Poland.
Circular EconomyConstruction TechImpact & Social GoodPropTechBrussels, BE
Nicolas Bearelle(Founder & Executive Chairman)inAlexandre Huyghe(Chief Executive Officer)in
Co-investorsEqual VenturesVictrixBanter CapitalBeechwood CapitalBlueberry VenturesCoalition Operators+2 more
Revive (getrevivehq.com) offers a curated resale edit of sought-after fashion pieces from brands such as Anine Bing, Farm Rio, Ruti, Bloomingdale's, and Lululemon.
Circular EconomyE-commerceMarketplaces
Co-investorsMute VenturesBanter CapitalBeechwood CapitalBlueberry VenturesCoalition OperatorsEqual Ventures+2 more
Functional beverage brand offering naturally-fermented kombucha.
Co-investorsBeechwood Capital
Sequoia Sciences is a biotechnology company developing vaccines, including a vaccine to prevent recurrent urinary tract infections, with programs spanning clinical development, regulatory strategy, and manufacturing.
BiotechHealthtechSaint Louis, US
GARY R ELDRIDGE, JR.(Executive Officer, Director)Gary Eldridge(Co-founder, President & CEO (Sequoia Vaccines))Kevin B. Bacon(President & CEO)inJim Spellmeyer(Chief Financial Officer)inMICHAEL J MERTZ(Director)GEORGE PAZ(Director)
Co-investorsCultivation Capital
Sequoia Vaccines develops vaccine treatments for infectious diseases, with a focus on prevention of recurrent urinary tract infections.
BiotechHealthtechMedical DevicesSan Diego, US
Gary Eldridge(President and CEO (since inception in 2012))Kevin B. Bacon(President & CEO)Michael Holmes
Premium sparkling water and beverages made with real squeezed fruit and zero added sugar.
Dave Burwickin
Co-investorsAlmanac InsightsGryphonKarpReillyNew Ground VenturesRiverPark VenturesVMG Partners
St.
HealthtechSt. Louis, US
Scott Wrightstone(Executive Officer)inMaureen Oehler(Executive Officer)Jason Pesterfield(Executive Officer, Director)inRyan Denney(Executive Officer)inMark Hunter(Executive Officer)inRobert Powers(Executive Officer)in
Co-investorsRC CapitalRex Health VenturesSolas BioVenturesAdvantage Capital PartnersVensana CapitalVersant Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Revive BrandsAdigica HealthAltheus TherapeuticsArvegenixAttuneDivergenceIntellicytNxthera IncPlumSingulexVenitiVeran
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesPlastomics, Inc. · finsmes.com · Oct 28, 2025
Frequently asked questions
- How many investments has Prolog Ventures made?
- Prolog Ventures has 32 tracked investments, 2 of which have exited.
- What stage does Prolog Ventures invest at?
- Prolog Ventures invests at the Series A, Late Stage stages.
- What is Prolog Ventures's typical check size?
- Prolog Ventures typically writes checks of $250K – $1M.
- What sectors does Prolog Ventures focus on?
- Prolog Ventures focuses on AgTech, Biotech, Consumer, Digital Health, FoodTech, Healthtech, Wellness & Fitness.
- Where is Prolog Ventures located?
- Prolog Ventures is headquartered in Clayton, US.
- Who does Prolog Ventures co-invest with?
- Prolog Ventures most often shares deals with Almanac Insights, BioGenerator Ventures, Corigin Ventures, among 33 tracked co-investors.
Similar investors
The March Group is a thematic venture capital firm backing exponential technology platforms at the intersection of food and medicine, focused on precision nutrition and intelligent health. It is anchored in the UC system ecosystem and partnered with UC Davis on the Aggie Venture Accelerator.
The Helm is a New York City-based venture firm focused on backing and elevating female entrepreneurs, investing in early-stage women-founded companies through a fund and an angel investor community.
Simon Capital is a German venture capital firm rooted in an entrepreneurial family heritage that backs mission-driven founders building sustainable businesses, providing capital plus access to industry networks and expertise.
Valor is a private investment firm focused on operational growth, investing in technology and technology-enabled companies that innovate and disrupt existing industries.
H Ventures incubates consumer brands grounded in microbiome science across food and beverage, personal care, and health sectors. The firm partners with leading microbiome scientists and commercial talent to develop products that improve human health and environmental sustainability.